Supplementary Data from PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING–Type I Interferon Signaling in Glioblastoma
<p>Cluster defining genes from scRNAseq data</p>
Na minha lista:
| Autor principal: | |
|---|---|
| Outros Autores: | , , , , , , , , , , , |
| Publicado em: |
2025
|
| Assuntos: | |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
| _version_ | 1849927638104145920 |
|---|---|
| author | Isha Mondal (16721699) |
| author2 | Oishika Das (16721702) Raymond Sun (16721705) Jian Gao (16721708) Bohyeon Yu (16721711) Aaron Diaz (16721714) Jinan Behnan (16721717) Abhishek Dubey (16721720) Zhipeng Meng (16721723) Emad Eskandar (16721726) Beisi Xu (14941098) Rongze Olivia Lu (16721729) Winson S. Ho (16721732) |
| author2_role | author author author author author author author author author author author author |
| author_facet | Isha Mondal (16721699) Oishika Das (16721702) Raymond Sun (16721705) Jian Gao (16721708) Bohyeon Yu (16721711) Aaron Diaz (16721714) Jinan Behnan (16721717) Abhishek Dubey (16721720) Zhipeng Meng (16721723) Emad Eskandar (16721726) Beisi Xu (14941098) Rongze Olivia Lu (16721729) Winson S. Ho (16721732) |
| author_role | author |
| dc.creator.none.fl_str_mv | Isha Mondal (16721699) Oishika Das (16721702) Raymond Sun (16721705) Jian Gao (16721708) Bohyeon Yu (16721711) Aaron Diaz (16721714) Jinan Behnan (16721717) Abhishek Dubey (16721720) Zhipeng Meng (16721723) Emad Eskandar (16721726) Beisi Xu (14941098) Rongze Olivia Lu (16721729) Winson S. Ho (16721732) |
| dc.date.none.fl_str_mv | 2025-11-24T23:20:17Z |
| dc.identifier.none.fl_str_mv | 10.1158/0008-5472.30700838 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/dataset/Supplementary_Data_from_PP2Ac_Deficiency_Enhances_Tumor_Immunogenicity_by_Activating_STING_Type_I_Interferon_Signaling_in_Glioblastoma/30700838 |
| dc.rights.none.fl_str_mv | CC BY info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Cancer Tumor Biology Immuno-oncology CNS Cancers Gliomas, Glioblastomas Immunology Immune responses to cancer Immunotherapy Combination immunotherapy Tumor Microenvironment Immune cells and the microenvironment |
| dc.title.none.fl_str_mv | Supplementary Data from PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING–Type I Interferon Signaling in Glioblastoma |
| dc.type.none.fl_str_mv | Dataset info:eu-repo/semantics/publishedVersion dataset |
| description | <p>Cluster defining genes from scRNAseq data</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_0952ff3cef2d52cb8d9b2608d59c605f |
| identifier_str_mv | 10.1158/0008-5472.30700838 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30700838 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY |
| spelling | Supplementary Data from PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING–Type I Interferon Signaling in GlioblastomaIsha Mondal (16721699)Oishika Das (16721702)Raymond Sun (16721705)Jian Gao (16721708)Bohyeon Yu (16721711)Aaron Diaz (16721714)Jinan Behnan (16721717)Abhishek Dubey (16721720)Zhipeng Meng (16721723)Emad Eskandar (16721726)Beisi Xu (14941098)Rongze Olivia Lu (16721729)Winson S. Ho (16721732)CancerTumor BiologyImmuno-oncologyCNS CancersGliomas, GlioblastomasImmunologyImmune responses to cancerImmunotherapyCombination immunotherapyTumor MicroenvironmentImmune cells and the microenvironment<p>Cluster defining genes from scRNAseq data</p>2025-11-24T23:20:17ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1158/0008-5472.30700838https://figshare.com/articles/dataset/Supplementary_Data_from_PP2Ac_Deficiency_Enhances_Tumor_Immunogenicity_by_Activating_STING_Type_I_Interferon_Signaling_in_Glioblastoma/30700838CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307008382025-11-24T23:20:17Z |
| spellingShingle | Supplementary Data from PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING–Type I Interferon Signaling in Glioblastoma Isha Mondal (16721699) Cancer Tumor Biology Immuno-oncology CNS Cancers Gliomas, Glioblastomas Immunology Immune responses to cancer Immunotherapy Combination immunotherapy Tumor Microenvironment Immune cells and the microenvironment |
| status_str | publishedVersion |
| title | Supplementary Data from PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING–Type I Interferon Signaling in Glioblastoma |
| title_full | Supplementary Data from PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING–Type I Interferon Signaling in Glioblastoma |
| title_fullStr | Supplementary Data from PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING–Type I Interferon Signaling in Glioblastoma |
| title_full_unstemmed | Supplementary Data from PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING–Type I Interferon Signaling in Glioblastoma |
| title_short | Supplementary Data from PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING–Type I Interferon Signaling in Glioblastoma |
| title_sort | Supplementary Data from PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING–Type I Interferon Signaling in Glioblastoma |
| topic | Cancer Tumor Biology Immuno-oncology CNS Cancers Gliomas, Glioblastomas Immunology Immune responses to cancer Immunotherapy Combination immunotherapy Tumor Microenvironment Immune cells and the microenvironment |